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SOMMARIO  
Gli esosomi sono nanovescicole di origine endosomiale, che 
rappresentano un mezzo importante di comunicazione cellula-cellula. 
Essendo coinvolti in diversi tipi di processi, sia fisiologici che patologici, 
sono diventati oggetto di sperimentazione clinica, nonostante molti 
meccanismi alla base della loro biogenesi rimangono tuttora sconosciuti. 
Quindi nel nostro laboratorio è stata messa a punto una metodica atta a 
produrre esosomi fluorescenti, in modo da poterne seguire la biogenesi 
nei diversi compartimenti intracellulari, il rilascio nell’ambiente 
extracellulare e la fusione con la membrana delle cellule riceventi. È 
stato quindi studiato, in un modello cellulare di melanoma umano, come 
questo precursore lipidico fluorescente è assorbito dalla cellula, 
accumulato all’interno del reticolo endoplasmatico, per poi diventare 
parte integrante della membrana degli esosomi. Queste nanovescicole 
fluorescenti sono state caratterizzate per dimensione, densità e presenza 
di marcatori proteici e successivamente è stata studiata con esperimenti 
di cinetica (5min – 24h) la secrezione. In seguito tale metodica è stata 
applicata allo studio della progressione del melanoma in condizioni di 
acidità microambientale. Nel melanoma è già noto che il pH 
microambientale è in grado di promuovere invasione e migrazione 
cellulare, e in questa tesi abbiamo analizzato il ruolo degli esosomi in tali 
processi. Quindi abbiamo studiato come cellule di melanoma umano, 
corrispondente a  uno stadio intermedio, coltivate in ambiente acido 
producano una maggior quantità di esosomi, con un’aumentata capacità 
di trasferimento in cellule bersaglio. Inoltre queste vescicole presentano 
un profilo proteico che permette alle cellule riceventi di acquisire 
capacità migratorie e invasive. Infine, attraverso studi di meta-analisi ed 
ex vivo su biopsie di pazienti, è stato confermato che le molecole 
arricchite negli esosomi secreti in condizioni di acidità possano 
rappresentare dei marcatori della progressione del melanoma, 
convalidando quindi il valore diagnostico e prognostico degli esosomi. 
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SUMMARY  
Exosomes, nanosized vesicles of endosomal origin, are worldwide 
recognized for their ability to transfer biological molecules, from cell to 
cell, crucial for both physiological and pathological processes. Hundred 
studies have been focused on exosome application also to clinics 
although biogenesis modalities are under investigation. Therefore, we set 
up a new effective fluorescent labelling strategy to trace exosome 
biogenesis and release with the aim to seek in human melanoma cell 
lines the impact that tumor progression may exert on their secretion and 
composition. Cells exposed to a fluorescent analogue of palmitic acid 
(Bodipy FL C16) were able to promptly synthetize fluorescent 
phospholipids, constituents of exosome membrane bilayer. Afterwards, 
we were able to follow exosome biogenesis from the intracellular sites of 
origin to cell secretion, chasing over time by direct cytofluorimetric 
analysis.  
To get insight into their function, we focused our studies on exosomes 
derived from melanoma cells maintained at low pH, which is a 
microenvironmental leverage for primary tumor to be transformed into 
widespread metastasis. When melanoma cells at specific intermediate 
stage were subjected to an acidic microenvironment, showed an increase 
in exosome release and transfer capability. Most importantly, when 
control melanoma cells were incubated with exosomes secreted in acidic 
medium acquired migratory and invasive capacities, demonstrating that 
exosomes carrying molecular payload can modify recipient cell program.  
Finally, meta-analysis and ex vivo studies confirmed the importance of 
acidic exosomes molecule content as marker of melanoma progression 
and so exosomes prognostic and diagnostic value.  
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INTRODUCTION 
Extracellular vesicles are a heterogeneous group of cell-derived 
membranous structures. Depending on their biogenesis, they can be 
distinguished in exosomes, that originate from the endosomal 
compartment and have a range in size from 50 to 150 nm in diameter, 
and microvesicles, which are generated by the outward budding and 
fission of the plasma membrane and are 50-500 nm in diameter, but can 
be up to 1 µm (Colombo, Raposo and Théry, 2014; Tricarico, Clancy and 
D’Souza-Schorey, 2017). Exosomes are produces as IntraLuminar 
Vesicles (ILVs) within the endosome and are secreted in the extracellular 
space after the fusion of the MultiVesicular Endosome (MVE) with the 
plasma membrane (Harding, Heuser and Stahl, 1984; Pan et al., 1985). 
Many different cell types are able to secrete membrane vesicles and this 
process is conserved throughout evolution, from bacteria to humans and 
plants (Deatherage and Cookson, 2012; Schorey et al., 2015; Robinson, 
Ding and Jiang, 2016). An important machinery for exosome biogenesis 
is the Endosomal Sorting Complex Required for Transport (ESCRT) 
(Colombo et al., 2013), which drive membrane shaping and scission after 
the clustering of ubiquitylated cargoes on microdomains of the limiting 
membrane of MVE (Hurley, 2008). This pathway can be then overlapped 
by syntenin and the protein ALG-2 interacting protein X (ALIX) (Baietti 
et al., 2012). However, it has been described another subpopulation of 
exosomes that is generated in an ESCRT-independent manner, that 
requires the ceramide (Trajkovic et al., 2008), formed by the neutral type 
II sphingomyelinase and the proteins of the tetraspannin family. 
Ceramide impose a negative curvature on membranes and is metabolised 
in sphingosine-1-phosphate to activate the G-protein-coupled receptor 
that seems essential for cargo sorting into ILVs. Tetraspannins can 
induce the inward budding of the microdomains in which they are 
enriched, thanks to their cone-like structure with an intramembrane 
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cavity that can accommodate cholesterol, and regulate the intracellular 
routing of cargoes (van Niel et al., 2011). Therefore, most cells produce 
subpopulations of MVEs, with a heterogeneous content of ILVs, 
characterized by a different protein composition and morphology, and 
different mechanisms can acts simultaneously or sequentially on MVE 
formation and specific cargo recruitment (Willms et al., 2016). 
The overlapping characteristics between the different types of vesicles, 
such as range of size and morphology, and the variable composition 
make difficult to distinguish them (Gould and Raposo, 2013; Kowal et 
al., 2016). Even though the generation occurs at different sites within the 
cell, during biogenesis are involved common intracellular mechanisms 
and sorting machineries. In fact, even for exosomes and microvesicles, 
lipids and membrane-associated proteins are clustered in discrete 
membrane microdomains that are important both to participate in the 
recruitment of soluble components, that are then sorted into extracellular 
vesicles, and to promote membrane budding and fission for vesicles 
biogenesis and secretion (Van Niel, D’Angelo and Raposo, 2018). 
Furthermore, most common used isolation methods do not really allow a 
separation of the different kind of vesicles, as ultracentrifugation and 
purification based on antigen beads, which does not take into account 
vesicles heterogeneity and isolates only subpopulations (Colombo et al., 
2013; Colombo, Raposo and Théry, 2014).  
Extracellular vesicles were first considered waste carriers, which were 
used by the cell to purge discarded elements, but nowadays they are 
considered an important mechanism for intercellular communication, 
capable to exchange components between cells (Cicero et al., 2015; 
Rashed et al., 2017). They can interchange protein, nucleic acid and lipid 
in both pathological and physiological conditions, acting as signalling 
vehicles for both short and long-range events (Simons and Raposo, 
2009). In fact, it is now becoming increasingly clear that EVs mediate 
disease progression. Many cells have the ability to release exosomes 
whose composition and biogenesis vary depending on the physiological 
or pathological state of their cell of origin, and can be either influenced 
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by others stimuli (Théry, Zitvogel and Amigorena, 2002). Therefore, 
they are considered an important diagnostic tool for different 
pathologies, such as lactation, immune response and neuronal function 
(Admyre et al., 2007), as well as implicated in pathological conditions 
such as liver diseases (Masyuk, Masyuk and Larusso, 2013), 
neurodegenerative diseases (Vella et al., 2007) myocardial infarction (Li 
et al., 2018) and cancer (Mathivanan, Ji and Simpson, 2010). Exosomes 
have been raised interest as potential source of disease biomarkers as 
well as to predict patient response to drugs, providing a tissue and cell 
type signature of the parental cells at the time of release since they are 
available in bodily fluids such as blood plasma, urine and saliva (Lane et 
al., 2018; Momen-Heravi, Getting and Moschos, 2018).  
For tumor progression and metastatization it is necessary a constant 
communication between cancer cells and the distant host environment. In 
this context, tumor-derived exosomes may contribute to this cross-talk by 
recruiting and reprogramming the tumor microenvironment (Kahlert and 
Kalluri, 2013). Tumor-derived exosomes have both pro- and anti- 
tumorigenic role in tumor progression. They can influence the tumor 
microenvironment by promoting angiogenesis or dysregulate immune 
surveillance in order to drive tumorigenesis (Greening et al., 2015), but 
together they can be mediators of immune response against cancer cells, 
as described for melanoma (Hong et al., 2016).  
Cutaneous melanoma is one of the most aggressive cancers, with an 
increasing incidence. Its progression is related to genetic, epigenetic and 
environmental factors that lead to a stepwise malignant transformation of 
melanocytes, allowing their uncontrolled proliferation and the acquisition 
of invasiveness (Miller and Mihm, 2006). One of the principal cues of 
progression is the microenvironmental acidification, that is the 
consequence of un upregulated glycolysis, so that the local 
microenvironment in human melanoma has been reported to be at pH 
between 6.4–7.3 (Wike-Hooley, Haveman and Reinhold, 1984). In the 
early phases, extracellular acidity influences tumor gene expression by 
up modulation of several genes encoding receptors, signal proteins, 
transcription factors, cytokines (Fukamachi et al., 2013), involved in 
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invasion, tissue remodeling, cell cycle control and proliferation (Rofstad 
et al., 2006; Moellering et al., 2008), thus leading to a more malignant 
cell phenotype.  
Melanoma cells have a high propensity to spread to distant sites, so that 
the prognosis is generally poor (Aubuchon et al., 2017). Both tumour 
expansion and the development of metastasis are regulated by the cross-
talk between cancer cells and the surrounding stromal components 
(Palmieri et al., 2015). This mechanism is mediated by exosomes, that 
are secreted by normal as well as malignant cell populations and drive 
many specialised functions implicated in intercellular signalling, protein 
cargo transport, proliferation, cancer development (Vlassov et al., 2012) 
and degradation of extracellular matrix by metalloproteases (Hakulinen 
et al., 2008; You et al., 2015). Moreover exosomes secreted by 
melanoma cells are able to migrate toward distant tissue to prepare the 
pre-metastatic niche (Peinado et al., 2012, 2017) and their fusion with 
their target cells prepare recipient tissue so that it becomes permissive for 
the subsequent homing of metastatic cells (Hoshino et al., 2015).  
The identification of predictive and prognostic biomarkers in cancer is an 
active area of research, but thus far only few molecules are relevant for 
clinical application. However, recent studies have proposed the use of 
exosomes in cancer for diagnostic and prognostic purposes, in a non-
invasive strategy. Indeed, these vesicles may represent a useful tool for 
characterization of the melanoma molecular signature (Tucci et al., 
2018). 
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AIMS OF THE WORK 
The aim of this study was firstly to elucidate the kinetic of exosome 
biogenesis and release, and to better characterize these vesicles. At the 
present time, the biochemical characterization and purification of 
exosomes from the entire population of extracellular vesicles remains a 
challenging investigative issue, only partially solved (Nolte- et al., 2012; 
Cicero et al., 2015; Kowal et al., 2016). Microvesicles (MV) and 
Exosomes (Exo) are similar in physical properties, as size and floating 
density, or in intrinsic characteristics, as molecular content. Thus, they 
can be easily mixed up once co-present in secretory fluids (Record et al., 
2014; Kreimer et al., 2015). Therefore, to monitor the traffic of the entire 
exosome population we developed in our lab an innovative methodology 
based on the use of a fluorescent fatty acid analogue, BODIPY FL C16 
(Bodipy C16), which is metabolized by the cell and generates the majority 
of phospholipids species, mainly directed in the endosomal compartment 
(Coscia et al., 2016). This lipid precursor enables to follow the kinetic of 
exosome release and of their uptake by target cells. Moreover, we aim to 
apply this new effective strategy for the isolation of a specific population 
of exosome from the bulk of extracellular vesicles, with the purpose to 
clearly characterize these vesicles and their biogenesis within the cell.   
Notably, this method represents an improvement on exosomes Flow 
Citometry-based studies so far reported, and provides a quantitative 
correlation between exosome uptake and cell functional effects. 
Then, by means of this procedure, we studied the role of exosomes in 
melanoma progression, driven by acidic microenvironmental pH, and as 
a function of tumor stage. To this aim we developed an in vitro model 
based on human melanoma cell lines representative of various steps of 
melanoma progression, cultured at acidic pH ranging between pH 6.0-6.7 
(WARBURG, 1956; Helmlinger et al., 1997). In fact, the extracellular 
pH in the core regions of tumors decreases to pH 6.7 and below because 
of lactate accumulation (Vaupel, Kallinowski and Okunieff, 1989; 
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Helmlinger et al., 1997). 
It has been previously described that the increase in the amount of 
secreted exosomes represents a hallmark of disease stage progression 
(Logozzi et al., 2009; Alegre et al., 2014), so we hypothesize that, since 
acid pH is known to be a microenvironmental leverage for primary tumor 
to be transformed into widespread metastasis, the cell responsiveness to 
acidic pH could result in an enhanced exosome secretion. 
However, since a role of exosomes, secreted in a microenvironmental 
acidic condition, in promoting melanoma progression was not described 
so far, we studied if exosomes alone are able to induce in control target 
cells the acquisition of new migratory and invasive capabilities. This 
ability highlights the importance of exosome content as the summary of 
the necessary pathways responsible for tumor progression. Therefore, we 
will analyse the vesicles protein profile and some proteins, that are 
upregulated in acid exosomes, will be checked in ex vivo assay as 
biomarkers of melanoma advancement. 
Altogether, the results of these experiments will provide an innovative 
technology to study exosome role in different biological processes and, 
in particular, in this study we will be able to detect key molecules 
involved in melanoma aggressiveness, which could be the object of new 
therapeutic and diagnostic strategies.  
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RESULTS 
1. Bodipy FL C16 is distributed in ER/late 
endosomes regions and is mainly metabolized in 
polar lipids. 
To get insight into the intracellular distribution of Bodipy C16, we first 
evaluated cell fluorescence in four human melanoma cell lines. After 2 
hours Bodipy C16 uptake, confocal microscopy images of all tested cell 
lines showed similar fluorescence distribution, likely restricted in the 
Endoplasmic Reticulum (ER)/late endosomal/MultiVesicular Body 
(MVB) compartments (Fig. 1a), and was not detected in the plasma 
membrane.  
To better characterize the subcellular localization of Bodipy C16 we 
performed confocal microscopy analysis (Fig. 1b) using LysoTracker, a 
probe for acidic organelles/lysosomes, and Filipin, a probe for free non-
esterified cholesterol that has been shown to label the recycling 
endosome area but not lipid droplets (Maxfield and Wüstner, 2012). 
Furthermore, colocalization with the Exosomal/MVB markers CD63 and 
CD81 highlighted that Bodipy C16 preferentially labels ER/late 
endosomal compartments. Remarkably, fluorescence seemed completely 
absent from the plasma membrane, labelled with the membrane 
impermeable protein reagent NHS-AF405, or from the cis-Golgi, 
labelled by GM130 (Demers et al., 2015).  
These results strongly suggest that Bodipy C16 allows for the 
identification of defined sub cellular compartments (supposedly ER and 
endosomes) involved in Exo biogenesis.  
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Figure 1 
 
 
 
 
To study the cellular transport kinetics of Bodipy C16 through the 
endo/lysosomal compartment, we performed pulse-chase experiments. 
Cells were pulsed with Bodipy C16 for different times, or pulsed for 15 
min and chased for different times up to 24 hours (Fig. 2a). The 
fluorescent probe is taken up by cells very rapidly, just after 5 min, and 
its uptake increases during pulse times. The fluorescence is rapidly 
localized in perinuclear ER areas and becomes more and more 
concentrated in specific regions, likely corresponding to late 
endosomal/MVB compartments. During chase times, spots fluorescence 
increases his intensity and after 24 hours is mostly chased out. To 
quantify the Bodipy C16 uptake and metabolism, we pulsed and chased 
cells for different times and measured cell fluorescence by Flow 
Citometry (FC) (Fig. 2b-c). The probe uptake, in Mel501 (MNI) cells, 
reached saturation after 5 hours (Fig. 2b), which has been since chosen 
Bodipy FL C16 is distributed in the ER and endosome region. (a) Confocal 
microscopy images of a panel of differently staged human melanoma cell lines, 
labelled with Bodipy C16 for 2 hours. (b) Colocalization of Bodipy C16 with 
specific organelle markers after a 2 hours pulse with Bodipy C16. Images are 
representative of at least two independent experiments. All scale bars indicate 
20 µm.  	
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for cell labelling. During chase times in fresh medium (Fig. 2c), we 
observed after 1 hour a drastic reduction of cell fluorescence to about 
30% of initial values that reaching 50% in 6 hours and slowly decreasing 
afterwards.  
 
 
Figure 2 
 
 
 
 
 
 
Pulse-chase experiments of cells labelled with Bodipy C16 and total lipid 
analysis. (a) Confocal microscopy analysis of MNI cells pulsed for different 
times with Bodipy C16 (upper panel) or pulsed for 15’ and chased for different 
times in complete medium (medium panel). Scale bar indicates 20 µm. Data 
are representative of at least three independent experiments. (b) Cells were 
treated with Bodipy C16 for the indicated amount of time (c) or treated for 15 
minutes, washed and chased in complete medium. Cell fluorescence was 
analysed by FC. Data are expressed as mean ± SEM (n = 3).  	
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To determine how the Bodipy is metabolized, and to be sure that there is 
no more free probe, we performed High Performance Thin Layer 
Chromatography (HPTLC). We first analysed cells at different chase 
times (Fig. 3a), and found that the fatty acid analogue is metabolized in 
polar lipids just after the end of pulse time, and the presence of free 
probe decrease during chase. Interestingly, Bodipy is not metabolized in 
triglycerids (TAG) and cholesterol (Chol), highlighting that the labelling 
is not attributable to lipid droplets. Next, we analysed fluorescent lipids 
in exosomes isolated after 1 hour or 24 hours of chase time (Fig. 3b), to 
ensure that fluorescence was associated to vesicles with metabolized 
phospholipids, and not to lipid probe aggregates. We found that pelleted 
exosomes are mainly composed by fluorescent polar lipids and there is 
negligible free probe. Moreover we checked the actual transformation in 
cell major phospholipid classes, both in cells and exosomes, at 1 hour 
and 24 hours of chase time (Fig. 3c). We found the presence of 
phosphatidylinositol (PI), phosphatidylserine (PS), 
phosphatidylethanolamine (PE), and most importantly 
bis(monoacylglyceryl)phosphate (BMP), a lipid previously described to 
be important for exosome biogenesis and found enriched in these 
vesicles (Record et al., 2014).  
This data suggest that cells internalize Bodipy C16 , that arises a plateau 
at 5 hours, and is transported to the endoplasmic reticulum were it is 
metabolized mainly in phospholipids. Then, the probe is directed to the 
endosomal pathway and becomes part of the exosome membrane. 
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Figure 3 
 
 
 
 
 
Total lipid analysis of Bodipy C16 labelled cells and exosomes. (a) Cells were 
pulsed with 7µM Bodipy for 15’ and chased for different times (0’, 5’, 30’, 2h, 6h, 24h). 
Total lipids were extracted from 500.000 cells and then neutral lipids were separated 
by HPTLC, using the appropriate solvent mixture. (b-c) MNI cells were pulsed with 7 
µM Bodipy for 5h and chased for 2h and 24h. Exosomes were isolated from cell 
culture supernatant at 1h chase time and, after addition of fresh medium to the same 
flask, at next 24h. Lipids were extracted and 40.000 cells and 8,6 x 108 exosomes for 
each chase time point were separated by HPTLC for (b) neutral lipids and (c) 
phospholipids. Data are representative of at least three independent experiments. 	
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2. Bodipy-Exo presents density, morphology and 
protein markers characteristic of exosome. 
This innovative methodology enables the fluorescent labelling of 
exosomes, which can thus be easily analysed by Flow Citometry (FC). 
Bodipy C16 is metabolized by the cell and transformed into principal 
exosome membrane lipids, thus vesicles can be counted and fluorescent 
population distribution can be visualized, enabling exosome tracing and 
characterization.  
As it has been described that in hepatocyte cell lines treatment with 
Palmitic acid alters exosome production (Lee et al., 2017), to be sure that 
visualized vesicles were not an artefact produced by the fluorescent fatty 
acid, we compared exosomes isolated from untreated cells, Bodipy C16-
treated cells, and Palmitic acid-treated cells. Total pelleted vesicles were 
run on a 10% SDS-PAGE gel and analysed for the main exosomal 
protein markers (Fig. 4a). We found that there are no differences among 
the three conditions; so we can infer that produced vesicles were not the 
result of any treatment, but represented the physiological production of 
this melanoma cell line. 
Conversely, for protein characterization and visualization, we labelled 
Bodipy-Exo with Alexa Fluor 647 NHS Ester, a water-soluble far-red 
dye that labels proteins on the external surface of vesicles (C16/AF647 
Exo). After labelling, fluorescent exosomes were loaded on top of a 
continuous iodixanol density gradient and twelve fractions were 
collected and analysed by FC (Fig. 4b). An equal volume of each fraction 
was precipitated using trichloroacetic acid (TCA) and run on a 10% 
SDS-PAGE gel that was fixed and scanned on a Thypoon 9500 laser 
scanner (Fig. 4c). The fluorescent protein pattern, corresponding to EVs 
external proteins, shows a specific profile for each fraction. Interestingly, 
fluorescent exosomes are enriched in fraction 4, which has a density of 
1.07 – 1.09 g/mL, slightly lower than what described (Willms et al., 
2016), and which presents a more heterogeneous protein profile. Western 
blot analysis, for the presence of exosome markers Flotillin-1, TSG101 
and CD81 (Fig. 4d), showed their presence in fractions corresponding to 
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the Bodipy-Exo fluorescent peak. Notably, TSG101 and Flotillin-1 are 
present in additional fractions non-corresponding to the fluorescent 
exosome peak. This is in agreement with experiments carried out in other 
cell models (Willms et al., 2016), showing that cells may secrete 
different subpopulations of exosomes with diverse densities. In addition 
it is well established that ultracentrifugation and density gradient does 
not allow a complete separation of vesicles of different origin, resulting 
in the presence of markers that might be exosome specific or not. 
Moreover, to further characterize exosome population and to investigate 
if fluorescent vesicles biogenesis is ceramide-dependent, we treated MNI 
cells with GW4869 (Fig. 4e), the neutral sphingo-myelinase (nSMase) 
inhibitor, described to reduce exosome release (Trajkovic et al., 2008; 
Cheng et al., 2017). In fact, we found that there is a significant decrease 
of exosome secretion by approximately 50%, both at 1h and at 4h of 
chase time.    
Therefore, we can infer that fluorescent vesicles described so far are 
attributable to exosome of endosomal origin, generated, at least in part, 
by a ceramide-dependent pathway. 
To confirm the co-expression of exosomal markers on Bodipy-Exo, we 
marked fluorescent exosomes with anti-CD81, anti-CD63 PE-conjugated 
antibodies and further separated double-labelled exosomes by upward 
flotation into discontinuous iodixanol density gradients. This last 
purification step was performed to separate the labeled EVs from 
unbound antibodies, which interfere in the FC analysis (Kormelink et al., 
2016). Fractions were analysed by FC for Bodipy-Exo count and co-
staining with fluorescent antibodies (Fig. 5a). Bodipy-Exo as well as 
CD81 or CD63 positive Bodipy-Exo regularly floated in a discrete peak 
ranging from densities of 1,08-1,15 g/mL, consistent with the density 
range classically reported for Exo (Colombo, Raposo and Théry, 2014), 
and slightly higher than what observed with top loaded density gradients. 
Double-labelled Bodipy-Exo with CD63 and CD81 were 8 % and 14 % 
respectively (Fig. 5b) with respect to the total Bodipy-Exo.  
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Figure 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fluorescent Exosome characterization. (a) Melanoma cell were treated with Bodipy 
C16, or Palmitic acid or left untreated for 5h at 37 °C, washed and incubated with 
complete medium. After 24h conditioned medium was recovered for vesicles isolation. 
Total collected vesicles were loaded on a SDS-PAGE gel for Western blot analysis with 
antibodies specific for TSG101, CD63, CD81 and CD9. (b) Bodipy-Exo were loaded on 
top of a continuous iodixanol density gradient (5-35%) and subjected to 
ultracentrifugation for 16 h at 100.000 x g in SW60 rotor. The resulting fractions (1–12) 
with increasing density were analysed by FC for Exo count. Fraction density were 
checked by refractometry. (c) Fractions from 1 to 7 were loaded on SDS-PAGE gel, 
which was scanned on a gel scanner for the analysis of fluorescent proteins pattern. (d) 
The presence of Exo protein markers Flotillin-1, CD81 and TSG101 was analysed by 
Western blotting using an equal volume of each sample. Data shown are representative 
of three independent experiments. (e) Bodipy-Exo were isolated from Mel501 cells pre-
treated or not with GW4869 for 19h, pulsed with Bodipy C16 and cultured for 1h and 4h in 
the absence or presence of 10 µM GW4869. Isolated fluorescent vesicles were counted 
by FC. All data are expressed as mean ± SEM (n = 3). 	
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Therefore, this data confirms that fluorescent vesicles contains proteins 
specific of exosomes. However, the low rate of expression of the two 
protein markers shows the heterogeneity of exosome population, 
probably depending on their differential biogenesis pathway. In fact, it 
has recently been described that exosomes represent a heterogeneous 
population with different expression of the typical protein markers, such 
as CD63, CD9, and CD81 tetraspanins (Kowal et al., 2016). 
 
 
Figure 5  
 
 
 
FC analysis for Bodipy-Exo co-localization with exosomal markers. (a) Exo 
distribution on discontinuous iodixanol density gradients, bottom loaded, after 
incubation with antibody against CD63 and CD81.Fluorescent vesicles were counted 
by FC analysis and double labelled vesicles were visualized. Fraction densities were 
determined by refractometry. (d) Dot plots of fractions corresponding to highest co-
localization peak. The gates inside the dot plots were determined on fluorescent 
Bodipy-Exo alone and appropriate isotype control. Data shown are representative of 
three independent experiments. 	
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Moreover, to further confirm that Bodipy-Exo are membrane vesicles 
and not protein aggregates or non-membranous particles, we performed 
electron microscopy analysis of 100.000 x g ultracentrifugation pellet 
deriving from untreated (Fig. 6a) or Bodipy C16 treated (Fig. 6b) cells. 
Electron microscopy images of the two negatively stained samples show 
a homogeneous mixture of vesicles with the typical exosome 
morphology and size (30-150 nm). Notably, some vesicles display 
protein spikes that protrude from membrane bilayer (white arrowhead). 
Scanning electron microscopy (SEM) of Bodipy-Exo shows a tri-
dimensional view of these vesicles, confirming the average diameter of 
this purified exosome population (Fig. 6c-d) and the protrusion of 
external proteins on the surface (white arrowheads). However, TEM 
analysis of the Bodipy-Exo population purified by iodixanol density 
gradient has demonstrated that fractions comprising the fluorescent peak 
quite exclusively contains vesicles with the typical exosome size (Fig. 
6e). Importantly, immunogold labelling of exosomes with antibody 
against Bodipy FL shows a poor gold signal of the fluorescent vesicles, 
probably due to the difficult antigen access (Fig. 6f), but confirming that 
fluorescent population is represented by vesicles with property and size 
characteristic of described exosomes. Moreover, anti-CD81 antibodies 
easily recognize proteins around the exosome surface (Fig. 6g), 
validating that analyzed vesicles have the typical exosome protein 
composition. 
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 Figure 6 
 
 
Transmission and Scanning Electron Microscopy analysis of Exosomes. 
Negative staining of exosomes from MNI cells labelled (b) or not (a) with Bodipy 
C16. (c) SEM analysis of Bodipy-Exo. (d) SEM micrograph at high magnification 
(300k) of a Bodipy-Exo. (e) Negative staining of iodixanol density gradient fractions 
containing fluorescent exosome peak (f) Immunogold labelling of Bodipy-Exo with 
rabbit anti-bodipy antibodies and 10nM gold conjugated anti-rabbit IgG antibodies. 
(g) Immunogold labelling of Bodipy-Exo with mouse anti-CD81 antibodies and 
10nM gold conjugated anti-rabbit IgG antibodies. 	
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3. Bodipy-Exo immunoprecipitation reveals 
exosome-specific protein markers. 
We tested the possibility to immune-isolate Bodipy-Exo by using an anti-
Bodipy FL specific antibody. This approach allowed us to separate a 
selected population of metabolically labelled exosomes and analyse them 
by Western blot. SDS-PAGE gels of immunoprecipitated Exo and 
supernatants were also scanned for fluorescence, either in the green 
channel for CFSE labeled proteins or in the red channel for AF647, to 
distinguish on a qualitative level between external (NHS-AF647) and 
internal (CFSE) exosome proteins (Fig. 7a). Bodipy-Exo or double 
labelled C16/AF647-Exo were immunoprecipitated with similar 
efficiencies (about 65%), showing that NHS-AF647 labelling does not 
affect antibody recognition of fluorescent lipids. Results indicate a 
distinct fluorescent proteins profile of immunoprecipitated Exo with 
respect to total Exo for either CFSE or NHS-AF647 labelling. 
Importantly, CFSE labelling confirms that Bodipy-Exo represent a 
population of protein-loaded vesicles. However, we found that there is 
just a slightly difference between external and internal protein profile, 
being most of exosome proteins present on the membrane. Western blot 
analysis showed the presence of classical Exo markers (Fig. 7b), such as 
HSP90, TSG101 and CD81 but remarkably not Flotillin-1 (Kowal et al., 
2016), a marker of EV not Exo-specific but present in total exosome 
fractions. Therefore, this new approach can be useful to determine the 
exosome specific markers and the purification of vesicle of endosomal 
origin, without the contamination of other type of extracellular vesicles. 
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Figure 7 
 
 
 
4. Exosome secretion starts within 5 minutes and is 
not affected by time labelling. 
Finally, to determine the timing of exosome biogenesis, and if different 
labelling time could affect the kinetic of exosome secretion, we pulsed 
and chased cells at different times.  
Firstly, we pulsed cells with Bodipy C16 for 15 min, 30 min, 2 or 5 hours, 
washed and chased cells in fresh medium. At different time points, 
Fluorescent exosome immunoprecipitation reveal exosome-specific protein 
markers. Immunoprecipitation was performed as described using an antibody against 
Bodipy FL. (a) Pelleted vesicles were treated with CFSE and NHS-AF647 for 30 min 
before immunoprecipitation. Green and red fluorescent proteins of total vesicles were 
run on a SDS-PAGE gel and analysed with a gel scanner. Data shown are 
representative of three independent experiments. (b) Exosomes recovered from 
conditioned medium after 24h chase were immunoprecipitated using antibody against 
Bodipy FL. Both immunoprecipitated and immunoprecipitation supernatants were 
loaded on a SDS-PAGE gel for Western blot analysis with antibodies specific for 
Flotillin-1, CD81, TSG101 and HSP90. Total Exo were used as positive control. 
Nonspecific signal from the immunoglobulins’ heavy (50 kDa, Tsg101 and Flotillin-1 
blot) or light (25 kDa, CD81 blots) chains used for immunoprecipitation are indicated (*).  
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culture medium was harvested, for Exo isolation, and fresh medium was 
added to the same flask (Fig. 8a). The kinetic of Exo release is the same, 
independently of the pulse times, and reaches a plateau at 6 hours, but 
the amount of secreted Exo is dependent on the initial load of Bodipy C16 
within the endosomal compartment.  
Since most of the fluorescent exosomes are secreted in the first hours of 
chase time, we sought to determine if we could define the time needed 
for Bodipy-Exo release (Fig. 8b). We then pulsed cells with Bodipy C16 
for 5 hours and harvested conditioned medium at different time points, as 
described for previous experiments. Interestingly, we found that the 
majority of exosomes is secreted in early times, suggesting that vesicles 
secretion during chase time is immediate.  
Exo released at different time intervals were analysed by Western blot 
(Fig. 8c), for the presence of major exosome protein markers. 
Densitometric analysis of protein bands (Fig. 8d) demonstrates that the 
intensity pattern follows the trend of Bodipy-Exo release. In particular, 
Exo markers as CD81 and CD63 are more abundant at 15 minutes, when 
Bodipy-Exo release reaches the highest peak. On the contrary, Flotillin-
1, an EVs marker not specific for Exo (Colombo, Raposo and Théry, 
2014), seems to increase over time, when Bodipy-Exo secretion 
decreases but probably EVs heterogeneity rises. 
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  Figure 8 
 
 
 
 
Exo biogenesis and release kinetic (a) Cells were pulsed with Bodipy C16 for 
different times, washed and chased in fresh medium. At the indicated time points, 
conditioned medium was harvested and amount of secreted Bodipy-Exo 
determined by FC. Data at each time point is the sum of Exo secreted in the 
interval between each wash/fresh medium addition. Data shown are representative 
of three independent experiments. (b) The amount of secreted Exo at different time 
intervals after a 5 hours pulse with Bodipy C16. Data are expressed as mean ± SEM 
(n = 4) (c) Exo secreted at different time points were run on a SDS-PAGE gel, 
blotted and probed with antibody against Exo markers. Equivalent volumes of each 
sample were loaded on the gel. Exo, secreted after 24h of chase time were used 
as positive control. (d) Densitometric analysis of the expression of tested proteins. 
For each protein, data are showed as percent of expression relative to the total of 
the density of all samples. The green line (Exo) represent the amount of Exo 
secreted at different time points.   	
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5. BSA and low temperature inhibit exosome 
internalization. 
Bodipy C16 labelling enables the quantification of exosome uptake in 
target cells, by FC analysis. We first performed a study about exosome 
internalization, with dose-response (Fig. 9a) and time-course (Fig. 9b) 
experiments, incubating fluorescent exosomes with untreated cells, and 
analysing the increase of cell fluorescence. Then, we found the suitable 
concentration and time for exosome incubation, which consists in 700 
exo/cell and 2 hours. Taking into account these two conditions, we 
analysed how exosomes internalization can be inhibited.  
The study of the interaction between exosomes and FCS is important 
because it is already known that these vesicles are enriched in the 
bloodstream to reach distant target cells (Peinado et al., 2012). 
Therefore, we were interested in understanding how serum affects 
exosome uptake. We performed different experiments, to study the 
effects of temperature (Fig. 9c), Bovine Serum Albumin (BSA) and Fetal 
Calf Serum (FCS) (Fig. 9d). In temperature dependent uptake 
experiments we found that both 18 °C and 4 °C temperature decrease the 
number of exosomes internalized per cell, in accordance with the block 
of endocytosis (Punnonen, Ryhanen and Marjomaki, 1998; Suesca et al., 
2013). We found that FCS decreases exosome internalization into cells 
and, interestingly, we can speculate that most of this inhibitory effect can 
be attributable to albumin.  
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Figure 9 
 
6. Enhanced Bodipy-Exo secretion at acidic pH 
depends on melanoma stage. 
We applied this methodology to decipher unknown steps of melanoma 
progression. Thus, we developed a model based on a panel of differently 
Exosome internalization is inhibited by BSA and low temperature. (a) Dose-
response, (b) Time dependent, (c) Temperature dependent and (d) Inhibition uptake 
of Bodipy-Exo on Mel501 cells. 30.000 cells were incubated with (a) increasing 
amount of exosomes or with 700 Bodipy-Exo per cell for (b) different time, or (c) 
different temperature, diluted in HANK’s buffer. Otherwise (d) cells were incubated 
with 700 exo per cell for 1 hour in medium containing different concentration of FCS 
or BSA. At the end of incubation, cells were analysed by FC for fluorescence. Data 
are expressed as mean ± SEM (n = 4). 	
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staged human melanoma cell lines, and evaluated the influence of acidic 
pH microenvironment on tumor progression. Melanoma can grow in a 
context of extracellular acidosis within the range of pH6.4 to 7.3 (Wike-
Hooley, Haveman and Reinhold, 1984; Vaupel, Kallinowski and 
Okunieff, 1989). To mimic in vitro the action of tumor 
microenvironment, we cultured different human melanoma cell lines in 
acidified media at pH 6.7 and pH 6.0.  
To better define the stage of the melanoma cell lines used, we 
summarized the classification and gene mutations (Fig. 10a), and 
evaluated whether molecules related to melanoma progression, such as 
E-, and N-cadherin, involved in epithelial-mesenchymal transition 
(EMT), Tyrosinase and AP2α were differently expressed (Fig. 10b). 
Results indicated the occurrence of EMT together with expressions of 
AP2α and Tyrosinase in Primary Invasive (PI: WM115) and Metastatic 
Invasive (MI: WM266-4) cells, in line with an advanced tumor stage. On 
the contrary, Early Primary (EP: Me1007) and Metastatic not Invasive 
(MNI: Mel501) being in a pre-EMT phase, showed a higher expression 
of AP2α and Tyrosinase, thus indicating an earlier phase of tumor 
progression. 
 
Figure 10 
 
Characterization of cell lines used. (a) Overview table depicting classification 
and gene mutations. Reported references are listed in Supplementary References. 
(b) Western blotting analysis of total cell lysates, with the indicated antibodies. For 
all cell lines, 20µg of protein were suspended in Laemmli sample buffer, with 
freshly added 50 µM DTT, and loaded on a SDS-PAGE polyacrylamide gel. 
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We first checked if microenvironmental acidity induced morphological 
changes in melanoma cell lines, and found in the MNI cells a spindle 
shape morphology after 24 h incubation, being cells significantly more 
elongated at pH6.0 and pH6.7, when compared to controls grown at 
standard conditions (Fig. 11a). MNI cells appeared gradually elongated, 
and, interestingly, the EP cells morphology was not affected by acidic 
pHs, thus indicating this early stage to be less-sensitive to pH variations.  
 
 
Figure 11  
 
 
Besides, we controlled if intracellular distribution of Bodipy C16 was 
affected by different pH conditions, thus resulting in an altered 
fluorescent exosome secretion.  
Effect of pH treatments on MNI and EP morphology and Bodipy C16 intracellular 
distribution. MNI and EP cells were cultured in control, pH 6.7 or pH 6.0 culture media 
for 24 h. Analysis of cell elongation (a) and perimeter (b) was performed by the 
determination of Feret’s diameter and cell perimeter of cell culture. (c) MNI cells were 
labeled with Bodipy C16 for 5h and incubated at the indicated pHs for 24h. Cells were 
afterwards fixed and analyzed by fluorescence under confocal microscopy. The nucleus 
was visualized with DAPI staining (blue). Scale bars, 10 µm. ***: p < 0.0001.	
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We labelled both MNI and EP melanomas with fluorescent probe, and 
analyzed them by confocal microscopy. After 24 hours incubation, either 
at neutral (ctr) or acidic pHs (pH6.7 or pH6.0), cell fluorescence 
appeared either diffuse in the endoplasmic reticulum area or restricted in 
spots (Fig. 11c).  
Then, to study the amount of secreted exosomes, on the basis of disease 
stage, and to reveal how exosome release by melanoma cells can be 
influenced by acidic pH, we used the above-described strategy by 
comparing Bodipy-Exo secretion either in EP and MNI, as well as in the 
PI and MI melanomas, deriving from the same patient.  
Bodipy-Exo were recovered from melanoma cell lines cultured at pH 6.0 
and 6.7 for 24 h and FC counted. The acidity of the medium significantly 
enhanced exosome secretion when compared to buffered medium (ctr) in 
MNI, but not in EP melanomas (Fig. 12a). One explanation might be that 
the acidic treatment does not influence exosome secretion in early 
primary melanomas due to their intrinsic scarcely aggressive nature.  
Secreted exosome count conducted on PI and MI cell lines confirmed the 
higher exosome secretion in advanced versus primary melanomas. 
Specifically, in standard culture condition MI produced 50 exosome per 
cell versus 25 secreted by PI, in line with its more aggressive nature (Fig. 
12b). However, in this case, acidic pH positively influenced exosome 
release in primary, but not in metastatic cell lines, thus suggesting that it 
can influence exosome secretion at a specific tumor developmental stage, 
i.e. only when the massive secretion of specific molecules is required for 
the spread of the tumor and the progression of the disease. Accordingly, 
PI resulting pH-sensitive, is already endowed with invasive capability, 
thus indicating a more advanced stage with respect to EP not responsive 
to acidic pH in terms of exosome release. The identity of these vesicles 
as exosomes was confirmed by the expression of the common exosome 
markers Tsg101, Alix and CD81 and the absence of calnexin (Fig. 12c,d) 
(Lötvall et al., 2014). 
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Figure 12 
 
7. Exosome biogenesis is enhanced after 1h of pH 
treatment. 
To investigate a potential trigger to enhanced exosome secretion we first 
evaluated intracellular exosomal markers expression (Alix and Tsg101) 
Bodipy-Exo secretion is affected by acidic (pH6.0 and pH6.7) treatment only in 
intermediate melanoma cell lines. EP, MNI, (a) PI and MI (b) cells were treated with 
C16 (7µm) for 5h and then cultured in control or acidic (pH6.0 or pH6.7) medium for 24h. 
Hereafter conditioned medium was subjected to ultracentrifugation for exosome 
isolation. Fluorescent vesicles were then counted by FC. The graph shows the number 
of secreted Bodipy-Exo per cell. (c,d) Western blot analysis of total isolated vesicles for 
the presence of principal exosome markers (Alix, Tsg101 and CD81) and the absence 
of Calnexin, a marker of ER used as a negative control. Data shown are representative 
of three independent experiments. * p < 0.05.  	
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in the MNI acidic pH-responsive (Fig. 13a) and in the MI not responsive 
cell lines (Fig. 10d). We found that Alix (Fig. 13b) was significantly 
upregulated after short time pH 6.0 exposure and decreased together with 
Tsg101 (Fig. 13c) after 24h, thus suggesting the enhanced exosome 
release as the result of an augmented biosynthesis and following 
upregulated secretion. Interestingly, these markers were found 
unchanged during 24h acidic treatment in MI cells (Fig. 13d,e,f), in line 
with their unresponsiveness to acidic pH.  
Overall, these findings suggest that melanoma stage is an important 
parameter for melanoma responsiveness at acidic pHs.  
 
 
Figure 13 
 
 
MNI and MI intracellular expression of exosome markers (a-c) MNI, and (d-f) MI 
cells were left untreated or pH 6.0 treated for the indicated times, then cells were 
lysed and 30 µg/lane analysed for Alix and Tsg101 by western blot. (a,d) 
representative western blots are showed. (b,e) Alix, and (c,f) Tsg101 expression 
were normalized against tubulin by densitometry analysis and expressed as fold 
increase. Mean±sd (n=3) *, p < 0,05 **, p < 0,01  	
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8. Acidic exosomes induces migration and invasion 
in melanoma cells. 
We evaluated whether acidic exosomes could play a role in melanoma 
progression and studied if they alone were able to transfer migration and 
invasion capability in control cells. In this set of experiments, we chose 
pH 6.0 value, because the exosome recovery is very high and used MNI 
cells for their increased response to acidic pH. 
It has already been demonstrated that acidic exosomes display a higher 
fusion capability with plasma membrane of target cells (Parolini et al., 
2009). Thus, we first measured the change in acidic exosomes uptake. 
Dose-response experiments indicated a higher transfer efficiency of 
acidic Bodipy-Exo (pH6.0), which was constantly reproduced at 
increasing vesicle doses (Fig. 14a). Cells treated with fluorescent 
exosomes were analysed at confocal microscopy to visualize vesicle 
distribution, and found that both classes of captured exosomes were 
visible in the cytoplasmic area around nucleus (Fig. 14b,c). 
 
 
Figure 14 
 
Acidic Bodipy-Exo have an higher transfer efficiency. (a) Cells were incubated for 2h at 
37°C with an increasing amount of Bodipy-Exo, ctr and pH6.0, and fluorescence analyzed by 
FACS. The number of incorporated exosomes per cell was calculated and represented in the 
graph. Points: mean ± S.D. (n=4). (b) and (c) Confocal microscopy analysis of MNI cells 
after 2h incubation with Bodipy-Exo (2x103 per cell) (b) ctr or (c) pH6.0. DAPI stains show 
the nucleus (blue). Green: Bodipy-Exo. Scale bars, 10 µm.  	
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We then wondered if pH culture medium of target cells could influence 
exosome transfer (Fig. 15). We found that both control and acidic 
Bodipy-Exo have higher transfer efficiency in acidic extracellular pH, 
excluding acidic exosome in pH 6.0 medium, that was even lower than 
control exosome at pH 7.4. This last result may further explain the higher 
exosome availability in pH 6.0 condition, being the re-uptake on cells 
decreased with respect to control.  
 
 
Figure 15 
 
 
 
 
Next, the functional role of these two classes of exosomes was explored 
through in vitro migration and invasion assays (Fig. 16a). MNI 
melanoma cells were incubated for 72 h with the same amount of 
exosomes (1x107) released from control or pH6.0-cultured cells. The 
uptake of acidic Bodipy-Exo induced a significant increase in cell 
migration and invasion, thus we hypothesized that a specific molecular 
content together with a higher amount of transferred acidic exosomes 
C16-exo uptake at extracellular acid pH. 17x106 Bodipy-Exo (ctr) and (pH6.0) 
obtained from (a) MNI and (b) EP cells, were incubated for 2h at 37° C with parental 
cells (0.05x106) at the indicated pHs. The number of incorporated exosomes per cell 
was calculated and represented as percentage of respective control at pH 7.4. Points: 
mean ± S.D. (n=3) *, p < 0,05; **, p < 0,01; ***, p < 0,005 vs respective pH 7.4 
condition; §§, p < 0,01 vs C16-exo ctr at pH 7.4 
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could be responsible of cell acquired aggressiveness. To exclude the 
enhanced cell migration and invasion as the result of increased cell 
proliferation, we examined the effects of control and pH6.0 Bodipy-Exo 
on MNI cell growth. After 72 h incubation, cell proliferation was not 
affected by exosome treatments either in time (Fig.16b) and dose-
response (Fig.16c) experiments.  
Altogether, these data highlight the exosome capacity to transmit 
molecular signals that make cells able to metastasize.    
 
 
Figure 16 
 
 
 
To address whether these results could mirror the in vivo process where a 
slow acclimation at low pH is required to select resistant cells 
(Moellering et al., 2008), we selected MNI cells for two months, by 
lowering pH culture medium, followed by 1 month re-acclimation at 
physiological pH (Fig. 17a). In line with 24 h pH 6.0 treatment, we 
observed no variation in cell proliferation (Fig. 7b) an elongated cell 
Acidic exo are able to induce migration and invasion in pH naïve cells. (a) Migration and 
invasion assays of MNI cells (3.5x104) after incubation with (10x106) Bodipy-exo ctr or pH6.0. 
Migration and invasion were evaluated after 72 hr of incubation by a colorimetric assay at 620 
nm. * p < 0.05. (b,c) Cell viability was assayed by trypan blue exclusion of dead cells. MNI cells 
(2x103) were incubated with Bodipy-exo ctr, pH6.7 and pH6.0 (5 x106) and counted at the 
indicated days, or with 1x106, 5x106, 1 x106 Bodipy-exo ctr, pH6.7 and pH6.0 and counted after 
two days. Histograms: means ± S.D. (n=3). Results indicate that in (e) and (f) the differences 
among ctr and pH6.0 are not statistically significant.  	
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morphology (Fig. 17c), and acquired migratory ability in acidic selected 
condition (Fig. 17d). Remarkably, exosomes obtained from acidic 
selected cells induced migration in control cells, thus confirming a stable 
pro-migratory role exerted by acidic microenvironment through 
exosomes.  
 
 
Figure 17 
 
 
 
9. Acidic exosomes display enrichment in metabolic 
pathways related to tumor aggressiveness.  
Looking for the different molecular cargos potentially responsible for the 
newly acquired metastatic properties, we investigated the protein 
composition of exosomes secreted by MNI cells upon acidic treatment by 
a quantitative mass spectometry analysis.  
MNI cells selection at acid pH. (a) Workflow of MNI selection at acid pH. RPMI 
medium was supplemented with MES 20 mM, Mops 20mM, HEPES 20 mM, and pH 
was lowered each two weeks to reach pH 7.1 and pH 6.7. Then, medium was 
replaced with RPMI pH 7.4 for 1 month to obtain MNI acid selected cells. At the end 
of acclimation cells were assayed for (b) growth, (c) morphology (magnification 10x) 
and (d) migration. MNI control and acid sel Bodipy-Exo were obtained as described 
in the manuscript, and same number (10x106) incubated for 72 h with MNI control 
cells for migration assay. (n=3) *, p< 0.05.  
                                                                           PhD in Cellular and 
Developmental Biology  
 	
							39																																								 																																																																																																																																															
Exosomes recovered after 24 h of cell culture at acidic (pH6.0) and 
control conditions were run on 4-12% SDS-PAGE and subjected to in-
gel trypsinization and the extracted peptides were then analyzed by 
Nano-HPLC. A total number of 186 and 157 proteins were identified in 
pH6.0 and control samples, respectively.  
The fluorescent vesicle preparation were further validated by the 
presence of 24 (pH6.0) and 21 proteins matching some of the most 
frequently identified exosome protein markers 
(http://exocarta.org/exosome_markers) (Table I). Moreover, the lack in 
our lists of melanosome markers, such as DCT and GPNMB, excluded 
any possible contamination with melanosomes, which are vesicles 
containing the pigment melanin and abundantly secreted from 
melanocytes (Dror et al., 2016). 
 
Table I 
 
 
Gene 
GenBank 
ID* 
Probe name 
Mentel-
Cox p-
value** 
HRAS 3265 212983_at 0.010599 
IQGAP1 8826 213446_s_at NS 
ACTN1 87 200601_at NS 
ACTN4 81 208636_at NS 
CDC42 998 214230_at NS 
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CFL1 1072 1555730_a_at NS 
CFL2 1073 233496_s_at 0.002532 
FN1 2335 210495_x_at NS 
NRAS 4893 202647_s_at 0.002301 
GSN 2934 202647_s_at 0.044629 
VCL 7414 200930_s_at NS 
CD44 960 229221_at NS 
TIMP3 7078 201147_s_at 0.029350 
THBS1 7057 201110_s_at NS 
TLN1 7094 203254_s_at NS 
CTNND1 1500 1557944_s_at NS 
ICAM1 3383 215485_s_at NS 
DNAJA2 10294 209157_at NS 
GANAB 23193 214626_s_at 0.003695 
HSP90AA1 3320 211968_s_at NS 
HSP90B1 7184 216449_x_at 0.040481 
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HSP90AB1 3326 200064_at 0.029072 
HSPA1L 3305 233694_at 0.048446 
HSPA5 3309 230031_at 0.026684 
HYOU1 10525 200825_s_at 0.037596 
VCP 7415 214990_at NS 
 
 
We found that 24 h incubation at low pH was sufficient to modify 
exosome protein profile, being more than 50% of the proteins up-
regulated, as displayed by the comparative Venn diagram (Fig.18a).  
Functional annotation analysis of these three data sets was performed 
interrogating KEGG pathway database (Fig. 18b).  
Taken together, these results show that exosome released at low pH 
contain specific proteins whose transfer to recipient cells can promote 
melanoma malignancy. 
Interestingly, in acidic conditions, functional categories such as 
proteoglycans, focal adhesion and protein processing in endoplasmic 
reticulum, responsible for melanoma migration and invasion, metastasis 
and survival (Knutson et al., 1996; Hess et al., 2005; Jiang et al., 2007), 
resulted over-represented. 
Meta-analysis of upregulated protein in acid exosomes through PrognoScan. The 
analysis was performed by interrogating PrognoScan database for gene expression in cancer 
tissue samples versus overall survival rates of patients with metastatic melanoma. All the 
listed genes refer to proteins involved in metastatic processes found upregulated in acid 
exosomes (see Additional Table 3). The analysis has been performed by using the dataset 
GSE19234, publicly accessible at GEO database (Gene Expression Omnibus database, 
https://www.ncbi.nlm.nih.gov/geo). 
* publicly accessible at https://www.ncbi.nlm.nih.gov/gene 
** Numbers depict Mentel-Cox p values for gene expression with significant difference in 
patient’s overall survival. Only values with p<0.05 are indicated. NS, patient’s overall 
survival not significant (p>=0.05) for the indicated high or low gene expression. 	
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Figure 18 
 
 
Further analyses by using Gene Ontology (GO, 
http://www.geneontology.org) confirmed the enrichement of acidic pH 
up-regulated proteins in some key biological processes (Fig.19) as cell-
cell adhesion, leukocyte migration, regulation of cell shape, small 
GTPase mediated signal transduction, EGFR signaling pathways, all 
associated with the migratory properties of the cells.  
 
10. Acidic exosomes content mirrors protein 
expression at metastatic site of melanoma 
patients. 
To find a clinical relevance of modified exosome content at acidic pH, 
we performed a meta-analysis of all the metastasis-related functional 
Proteome characterization by HPLC-MS/MS of control and pH6.0 exosome 
reveal a different protein pattern. Exosomes were obtained after ultracentrifugation. 
(a) Venn diagram depicting the overlap of upregulated and downregulated pH 6.0 
proteins with respect to control condition. (b) Functional analysis of the 
downregulated, equally expressed and upregulated proteins at pH6.0. Only over-
represented metabolic pathways with P ≤ 10-2 were considered.  	
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Figure 19 
 
categories, by using Prognoscan database (Mizuno et al., 2009). 
Interestingly, around 50% of these genes, represented by HRAS, 
GANAB, CFL2, HSP90B1, HSP90AB1, GSN, HSPA1L, NRAS, 
HSPA5, TIMP3, HYOU1, showed a positive correlation of their high 
expression in cancer tissues and poor prognosis in patients with 
metastatic melanoma (Fig. 20a). These data were further confirmed 
Proteome characterization by HPLC-MS/MS of control and pH6.0 exosome 
reveal a different protein pattern. GO enrichments of pH6.0 upregulated proteins. 
Only over-represented categories with P ≤10-2 were considered. 	
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analysing by western blot the expression of a representative set of these 
gene products, i.e. HSP90, CFL2, GSN in exosomes released at acidic 
pH (Fig. 20b). As expected, the upregulation of all proteins tested was 
evident in acidic exosomes compared to control. 
 
 
Figure 20 
 
Meta-analysis of significant metastatic upregulated proteins in acid exosomes 
through Prognoscan (a) Kaplan-Meyer curves depicting the Overall Survival of 
metastatic melanoma patients with high (red lines) or low (green lines) expression of the 
genes listed in Table 1, that resulted statistically significant. Mentel-Cox p-values for 
each plot are showed. (b) Western blotting analysis of ctr and pH6.0 exosomes (20 µg). 
Cell lysate was used as positive control. Expression of CFL, GSN and HSP90αβ is 
shown. Ponceau red is shown for equal exosome protein amount.  	
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Finally, the expression levels of CFL, GSN and HYOU1 proteins were 
evaluated on some representative bioptic samples from melanoma 
patients (Fig. 21). Interestingly, a general increase in the level of these 
proteins was observed in lymph node autologous metastases compared 
with their primary counterparts. 
 
 
Figure 21 
 
 
All together, these data demonstrate that acidic exosomes contain 
molecules representative of the protein profile in metastatic sites of 
melanoma patients. This may indicate acidic exosomes as a diagnostic 
tool of poor prognosis in melanoma patients. 
Immunohistochemistry on bioptic samples. Confocal immunofluorescence 
analysis with the indicated antibodies on primary (apical and mid region), and 
metastatic melanoma biopsies from the same patient. Ki67 labeling was used as 
internal control. Red, CFL, GSN, HYOU1; blue, DAPI; green, Ki67. Bar 50 mm  	
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DISCUSSION 
Exosomes have entirely emerged to be important contributors to cancer 
biology. They represent important mediators for intercellular 
communication and are able to modulate recipient cell phenotype and to 
induce changes in components of the tumor microenvironment, enabling 
disease progression. Their content, number and size differ under defined 
microenvironmental conditions, such as those developed during tumor 
progression (Peinado et al., 2012). Almost all cell types, based upon their 
physiological state, have the capability to discharge vesicles (Nagarajah, 
2016; Gomez et al., 2018). Although too often they are generically 
named exosomes this nomenclature should be applicable only to 
intraluminal vesicle whose biogenesis strictly attain the multi-vesicular 
bodies (MVBs) derivation. This kind of ambiguity comes from an 
absence of demonstration of their intracellular origin and lack of clearly 
defined and decisive methods to identify EVs types.  
In order to track the intracellular flow linked to exosome biogenesis 
towards vesicle release, we developed an innovative methodology to 
metabolically label fluorescent exosomes whose number and 
fluorescence intensity can be precisely analyzed by Flow Cytometry 
(FC) (Coscia et al., 2016). The use of conventional FC to identify 
purified exosomes represented a step forward with respect to the 
complex instruments previously used for this purpose (Pospichalova et 
al., 2015). 
We observed by TLC analysis that treating cells with the fluorescent 
palmitic acidic analogue BODIPY FL C16 (Bodipy C16), this is promptly 
metabolized within the Endoplasmic Reticulum (ER), likely in its smooth 
portion, into the majority of phospholipid species including the 
unconventional Bis(monoacylglycero)phosphate (BMP). Importantly 
BMP, being a specific membrane marker of the MVB and intraluminal 
vesicles compartments, can discriminate exosomes from microvesicles 
that are originated from the plasma membrane (Record et al., 2018). 
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Whereby this methodology embodies an effective strategy to study 
exosome biogenesis, to monitor their release in the external milieu and to 
assess their transfer into recipient cells. All in all, by means of 
experimental procedures such as HPTLC and confocal microscopy we 
brought into evidence a direct Bodipy FL C16 metabolic lipid flow that 
starts from ER, goes through late endosomes/intraluminal vesicles 
formation and terminates in an extracellular release of fluorescent 
exosomes.  
Therefore, in this study, we provide evidence that a population of 
exosomes can be dynamically tracked over time from the metabolic site 
of their membrane envelope formation towards extracellular secretion. 
Moreover, lipid extraction of fluorescent cells and exosome 
unambiguously demonstrate that the observed intracellular fluorescence 
was not due to free probe diffusing in the cells, either alone or bound to 
the BSA used as carrier. Noteworthy, neutral lipid analysis showed that 
Bodipy C16 is not metabolized to triglycerides or cholesterol esters, lipids 
specifically secluded in the lipid droplets storage compartment (Pol, 
Gross and Parton, 2014). These observations are in agreement with 
previous studies (Louie et al., 2013) where it has been described that 
tumor cells, primarily metastatic cells and in particular melanoma cells 
(Kwan et al., 2014), incorporate exogenous palmitate into pathways that 
generate structural lipids rather than lipids destined to oxidative 
pathways or lipid droplets (Akoumi et al., 2017). Exclusion of lipid 
droplets labelling is substantiated by the strong intracellular 
colocalization of Bodipy fluorescence with Filipin, a stain specific for 
unesterified cholesterol. On the other hand, exosomes collected at 
different times of chase show that Bodipy C16 is present almost 
completely in the form of polar lipids with very little residual free 
Bodipy C16.  
These data are consistent with the notion that the ER forms functional 
contacts with endosomes (van der Goot and Gruenberg, 2014). 
Moreover, it has been shown that during their biogenesis endosomes 
become more tightly associated with the ER (Friedman et al., 2013) and 
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that one function of ER-endosome contact sites is the transfer of free 
cholesterol, taken up from plasma membrane, into early endosomes 
(Rocha et al., 2009). An attractive hypothesis is that fluorescent lipids 
metabolized in the ER are incorporated into endosomes at the 
ER/endosomes contact sites, which later undergo intraluminal vesicles 
formation and maturation into MVB.   
To clearly characterize exosome we performed iodixanol density 
gradient separation and electron microscopy. When exosome pellets 
were run on iodixanol density gradients and each fraction analysed for 
Bodipy-Exo content and for exosome markers expression, these 
experiments revealed that the Bodipy-Exo population separated as a 
homogenous discrete peak and that the corresponding fractions were 
positive for exosome markers Flotillin-1, TSG101 and CD81. Moreover, 
TEM analysis of the iodixanol gradient fractions containing the 
fluorescent peak showed vesicles of the exosome characteristic size that 
were positive for Bodipy and CD63. Finally, to further prove fluorescent 
exosome biogenesis, we treated cells with GW4869, an inhibitor of 
neutral sphingomyelinase, that is commonly used to block exosome 
secretion (Li et al., 2013; Wang et al., 2014; Essandoh et al., 2015). 
Accordingly, we found that this treatment decreases the number of 
released vesicles, revealing the ceramide-dependent biogenesis of 
Bodipy-Exo. 
Further characterization of Bodipy-Exo was obtained by monitoring by 
FC the presence of the tetraspanins CD63 and CD81 on fluorescent 
exosomes. Fluorescent vesicles exhibited colocalization with these 
exosomal markers, respectively 8% and 14% for  CD63 and CD81 which 
is in fair agreement with previous independent data obtained by others 
using a more sophisticated FC analysis with dedicated instrument 
settings (Kormelink et al., 2016).  
Moreover, an additional demonstration of the exosomal nature of 
Bodipy-Exo came from the ability of an antibody against the Bodipy 
moiety of fluorescent lipids to specifically immunoprecipitate fluorescent 
vesicles. Here, the use of CFDA-SE (carboxyfluorescein diacetate 
succinimidyl ester), a fluorescent protein reactive reagent that that is 
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cleaved of acetate groups by vesicles esterases enzymes to form an 
amine-reactive fluorescent protein products, confirmed that Bodipy-Exo 
are intact vesicles, containing a protein cargo. Notably, our results 
highlight that flotillin-1, whereas co-isolates with exosomes of the same 
specific floating density, is excluded from the immunoprecipitated 
fluorescent Exo population, which is in agreement with previous reports 
showing that flotillin-1 cannot be considered an exosome marker (Kowal 
et al., 2016). Together, the lines of evidence presented so far strongly 
suggest that the metabolically labelled fluorescent vesicles population are 
indeed bona fide exosomes. 
To fulfil the purpose to determine the kinetic of exosome secretion, we 
made out pulse-chase experiment. We were able to identify secreted 
exosomes as soon as 5 minutes after labelling, and a principal secretion 
peak at 1 hour, that could represent the time needed for MVB to reach 
the plasma membrane.  Importantly, the pulse time does not influences 
the kinetic of vesicles release, but vary the number of detected vesicles, 
due to the amount of fluorescent probe absorbed by the cell and so the 
less intense exosome fluorescent labelling. Therefore, exosome release is 
independent from probe incorporation, supporting the idea of the 
existence of a cellular mechanism that organizes such flow. 
This exosome labelling strategy allows challenging application to 
experiments concerning the mechanism underpinning exosome uptake on 
target cells. In fact by dose-response experiments, we were able to 
identify among FCS components, BSA, the factor that prevents exosome 
autologous uptake. The hypothesis is that albumin present in bloodstream 
can help exosome to preserve its structure and stability enabling these 
vesicles to reach and be absorbed only by specific target cell. However, 
this approach represents only the initial step for the study of pathways 
and molecules involved in the specific recognition and fusion of 
exosomes on target cells, and for future studies that aim to use exosome 
as therapeutic tool.  
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So far, we show that this cell labelling strategy enable the exosome in 
vitro investigation at any stage of their development and in any 
environmental condition, such as extracellular acidic pH.  
During tumor progression, microenvironment is an important and unique 
platform of cancer biology that is pitoval for either promoting immune 
tumor rejection or protecting the tumor and promote their progression 
(Zhang et al., 2017). One aspect of tumor microenvironment is pH 
fluctuation, which occurs during tumor progression. Then, we applied the 
above-described methodology to monitor exosome secretion in various 
microenvironmental pH conditions.  
Microenvironmental acidic pH exerts multiple roles in tumor 
advancement that imply local invasion and dissemination of cancer cell 
(Robey et al., 2009; Estrella et al., 2013) activation of MMPs (Fiaschi et 
al., 2013), and impairment of the immune response (Lardner, 2001). In 
the melanoma model, external low pH was found to promote metastasis 
(Rofstad et al., 2006) and to affect exosome traffic (Parolini et al., 2009). 
An exosome functional role in the development of tumor was principally 
described in the later stages of melanoma progression, being exosomes 
involved in the production of long-distance metastases (Hood, San and 
Wickline, 2011). Nonetheless, a role of exosomes in driving metastatic 
properties, at intratumoral level under acidic pressure, was never defined 
so far. 
We studied a panel of four differently staged human melanoma cell lines, 
that we described and divided into two group: i.e. BRAF wild type or 
mutated and with low or high expression of E- and N- cadherin 
representing epithelial-mesenchymal transition (EMT) process. The 
analysis of the amount of secreted exosomes in all cell lines, helped us to 
define an intermediate stage sensitive and responsive to environmental 
acidic pH. In fact, cells that were responsive to acidic pH induced an 
enhanced exosome release. Exosomes secreted under this condition have 
an altered proteomic profile that has the potential to affect the phenotype 
of target cells, thus inducing migratory and invasive properties on control 
melanoma cells. It is conceivable that increased exosome release at this 
stage is crucial for the progression of the disease at a step in which the 
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maximal spread of newly acquired and specific molecular information 
are needed to drive and sustain tumor aggressiveness. Notably, changes 
induced by microenvironmental acidic pH are stable, even after re-
acclimation at pH 7.4, as demonstrated by experiments of cells in acidic 
selection. 
In melanoma the correlation between amount of secreted exosomes and 
disease stage has not yet been completely clarified, being reported in 
some studies an increased amount of exosomes in plasma from advanced 
patients (Logozzi et al., 2009; Alegre et al., 2014), and in other studies 
similar numbers of exosomes in patients at different clinical stages 
(Hood, San and Wickline, 2011; Lazar et al., 2015). We here found that 
metastatic melanoma release a higher amount of exosomes than primary 
melanoma, supporting the idea that the number of secreted vesicles is a 
hallmark of disease stage.  
We here reported that the increase in secreted exosomes is mainly due to 
a higher vesicles biosynthesis and release in the extracellular space. 
Investigating the influence of medium pH on exosome transfer, we found 
that the increased exosome secretion at pH 6.0 may be the result of a 
reduced re-uptake on target cells. So, these two issues represent some 
steps probably involved in the mechanism of exosome release and 
transfer. 
Finally, to explore change in exosome protein profile stimulated by pH 
variations, we carried out a comparative proteomic analysis of exosome 
secreted under control and acidic conditions. We identified some protein 
categories upregulated in acidic exosomes, that were interestingly 
already found related to metastatic processes (Lazar et al., 2015). Due to 
the different nature of these molecules, we can speculate about 
independent functional roles occurring in cell transformation, and 
ultimately leading to enhanced cell aggressiveness.  
Nowadays, in melanoma a reliable diagnostic and prognostic 
significance of exosomes has yet to be demonstrated (Alegre et al., 2016; 
Tucci et al., 2018). To establish a clinical relevance of exosome protein 
content, we applied a meta-analysis approach, using PrognoScan 
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database. We found that in acidic exosomes about 50% of upregulated 
molecules are correlated with poor prognosis in melanoma patients, that 
are HRAS, GANAB, CFL2, HSP90B1, HSP90AB1, GSN, HSPA1L, 
NRAS, HSPA5, TIMP3, HYOU1. Moreover, the relevance of a set these 
molecules (CFL2, GSN and HYOU1) was confirmed by ex vivo 
experiments on bioptic samples of primary melanoma and autologous 
lymph-node metastases, (patient with Clark’s level IV), whereas Hsp90 
protein overexpression was previously described (Huang et al., 2009). 
Thus, these molecules may represent a melanoma stage specific signature 
and could be the object of new target therapies against melanoma 
development. In particular, we can hypothesize a prominent role for GSN 
and CFL2 in inducing cell migration, through the actin cytoskeleton 
reorganization, thereby directly modulating the migratory behaviour of 
melanoma cells. 
In conclusion, we here described the key role of transferred vesicles 
together with their specific content in the regulation of tumorigenic 
cellular effects, opening the way for future studies focusing on 
mechanisms interfering with the production, transfer or uptake of acidic 
exosomes.  
Altogether, these findings contribute to a better understanding of the role 
of exosomes in a specific stage of melanoma progression driven by 
extracellular acidity. The specific content of exosomes produced under 
acidic conditions may acquire a prognostic and therapeutic value.  
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MATERIAL AND METHODS 
1. Cell lines 
We utilized Me1007 early primary melanoma (EP) and Mel501 
metastatic not invasive (MNI) that were obtained by Istituto Nazionale 
Tumori (Milan, Italy), authenticated according to a standard short 
tandem repeat-based genotyping at Ospedale Policlinico San Martino 
(Genova, Italy), and periodically tested for mycoplasma contamination. 
WM115 primary invasive (PI) and WM266-4 metastatic invasive (MI) 
are commercially available and, upon arrival, were expanded, freezed 
and stored under liquid nitrogen.  
Mel501 represents a primary low invasive melanoma, WM115 is a 
primary invasive and WM266-4 an advanced metastatic melanoma. 
WM115 and WM266-4 were obtained from the same patient.  
It might be interesting to evidence that Me1007, and Mel501 carry no 
classical mutations, whereas the other cell lines are B-RAF mutated 
(V600D) (Additional file 1). Melanoma cells were cultured in RPMI-
1640 or Dulbecco modified Eagle’s medium (DMEM) (GIBCO by Life 
Technologies) supplemented with 10% fetal calf serum (FCS), in a 
humidified 5% CO2 incubator.  
The culture media at various pHs were obtained as follows. For pH 6.7 
condition, we minimized the pH change during the cell culture by 
addition of 20 mM MOPS (3-(N-morpholino) propanesulfonic acid) to 
medium containing FBS, then adjusted with HCL 1N to pH 6.7. A 
stronger acidic condition (pH 6.0) was obtained by the addition of HCl 
1N to medium containing FBS, that allowed a cell culture pH fluctuation 
between 6.0 and 6.3. After 24 h incubation pH was evaluated by pH 
meter and found unchanged for pH 6.7 condition, whereas in case of pH 
6.0 condition ranged between 6.1-6.3. 
For long time acidic selection, RPMI medium was supplemented with 
MES 20 mM, Mops 20mM, HEPES 20 mM. pH was lowered each two 
weeks to reach pH 7.1 and pH 6.7. Then, medium was replaced with 
RPMI pH 7.4 for 1 month to obtain MNI acidic selected cells. 
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The bioptic melanoma specimens used in this study were obtained from 
the archives of the Istituto Dermopatico dell'Immacolata-IRCCS (Rome-
Italy). Signed informed consent was obtained by patients. For each 
patient, melanoma samples, including primary and autologous 
metastasis, were analyzed. Sampling and handling of human tissue 
material were carried out in accordance with the ethical principle of the 
Declaration of Helsinki.  	
2. Cell labelling 
BODIPY FL C16 fatty acid (Bodipy C16) (Life Technologies) was 
prepared as described (Coscia et al., 2016). Briefly, one aliquot (100 µL) 
of 1 mM stock in methanol of Bodipy C16 was dried under nitrogen gas, 
resuspended with 30 µL of 20 mM KOH, heated for 10 min at 60 °C and 
finally resuspended in 70 µL PBS containing 2% fatty acid-free bovine 
serum albumin (FF-BSA, Sigma-Aldrich). MNI and EP cells (50% 
confluence) were incubated with Bodipy FL C16 (4,4-difluoro-5,7-
dimethyl-4-bora-3a,4a-diaza-s-indacene-3-hexadecanoic acid) (C16) (Life 
Technologies) by addition of 7 µM C16 in medium supplemented with 
0.3% FCS (labelling medium) for 5 h at 37 °C. Then, cells were washed 
with H-BSA, to remove lipid excess, and complete culture medium was 
added. 
Palmitic acid were prepared as described for Bodipy C16. Aliquotes were 
resuspended in 20mM KOH, PBS 2% FF-BSA and were used for cell 
culture treatment at a final concentration of 7 µM in cell labelling 
medium, for 5 h at 37 °C. Cells were washed twice with H-BSA and 
complete culture medium was added. 
Conditioned medium was harvested after 24 hours and processed for 
exosome isolation or kept at 4 °C up to a week. 
 
3. Cell treatment with GW4869 
The nSMase inhibitor, GW4869 (Sigma, USA) was stored at +4 °C as a 
5 mM stock suspension in DMSO. For cell culture treatment, the 
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suspension was diluted into a working solution (10µM) in culture 
medium. Cells were pre-treated with GW4869 or DMSO (ctr) for 19h, 
and then were labelled with Bodipy C16 for 5 hours at 37 °C in cell 
labelling medium with GW4869 or DMSO. At the end of the incubation, 
cells were washed twice and complete medium containing GW4869 or 
DMSO were added for the indicated times. Conditioned medium was 
processed for Bodipy-Exo isolation or kept at 4 °C up to a week. 
 
4. Exosome isolation 
Conditioned medium was centrifuged at 2,000 × g for 20 minutes to 
remove cells and cell debris. Supernatant from previous centrifugation 
was centrifuged at 10,000 × g to remove bigger microvescicles. Then, for 
exosomes isolation, the 10K supernatant was centrifuged at 100,000 × g 
(100K) for 3 hours, and pellet was washed in 12 mL of PBS at 100,000 × 
g for 3 hours. All ultracentrifugation steps were performed at 4 °C using 
a SW41 Ti rotor (Beckman Coulter). Exo and MV were stored at 4°C 
with Protease and Phosphatase Inhibitor Cocktail (Roche) for Exo count 
and further analysis. 
 
5. Fluorescent labelling of Exosome proteins 
To fluorescently label exosome proteins, freshly pelleted vesicles were 
resuspended in PBS containing 10 µM of the membrane permeable 
reagent CFDA-SE (Life Technologies), and incubated for 60 min at RT. 
Alternatively, external Exo proteins were labelled with 10 µM of the far-
red fluorescent protein reactive dye Alexa Fluor 647 NHS Ester 
(Succinimidyl Ester) (NHS-AF647, Life Technologies, catalog# 
A20006) for 30 min at RT (C16/AF647 Exo). At the end of the incubation 
10 mM L-Glutamine was added to stop the reaction.  
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6. Exosome biogenesis 
MNI cells cultured to 50% confluency were pulsed with 7 µM Bodipy 
C16 for different times at 37 °C in cell labelling medium, washed twice 
with PBS and chased in fresh complete medium. Conditioned medium 
was harvested at time intervals, adding at each time point fresh complete 
medium. The cycle harvest/fresh medium addition was repeated at 
different time points, as indicated. Exosomes were isolated from 
conditioned medium by differential ultracentrifugation as described 
above, counted by flow cytometry (FC) and analysed by western blot for 
specific Exo markers.  
 
7. Flow Cytometry Analysis and quantification of 
Exosomes 
Flow cytometry (FC) of Bodipy-Exo was performed on a Gallios Flow 
Cytometer (Beckman Coulter) using an optimized procedure as 
previously described (Coscia et al., 2016). Briefly, 5 µL of fluorescent 
Exo or MV were mixed with 20 µL of Flow-Count Fluorospheres 
(Beckman Coulter) and further diluted with PBS to a final volume of 200 
µL. FC analysis was performed by plotting fluorescence at 525/40 nm 
(FL1) versus log scale side scatter (SSarea). The instrument was set at 
flux high and the analysis was stopped at 2,000 Flow-Count 
Fluorospheres events. Fluorescent EVs total number was established 
according the formula: x = (((y × a)/b)/c) × d where y = events counted at 
2,000 counting beads; a = number of counting beads in the sample; b = 
number of counting beads registered (2,000); c = volume of sample 
analysed; and d = total volume of exosome preparation. Kaluza Software 
v. 2.0 (Beckman Coulter) was used for FC analysis.  
 
8. Lipids extraction and analysis 
Lipid extraction from cells and exosomes was performed according to 
Folch procedure (FOLCH, LEES and SLOANE STANLEY, 1957).  
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Briefly, cells and exosomes were resuspended in 1,5 ml H2O and then 6 
ml of Chloroform/Methanol (2:1, v/v) were added. Samples were 
centrifuged for 15 min at 1.500 x g,  upper phase and interphase were 
discarded and lower phase was dried under N2 flow. Neutral lipids were 
separated on silica gel 60 plates (Merck) with a solvent system of 
hexane/diethyl ether/acetic acid (70:30:1, v/v/v). The zones on silica gel 
corresponding to phospholipids (PL) were scraped off, extracted with 
chloroform/methanol (2:1, v/v) and further developed by high-
performance thin-layer chromatography (HPTLC) with a solvent system 
of chloroform/methanol/32% ammonia (65:35:5, v/v/v/v). Fluorescent 
lipids were visualized by scanning with a Typhoon 9200 scanner 
(Amersham Biosciences). Non fluorescent lipid standards were detected 
by staining with 3% copper acetate solution in 8 % phosphoric acid and 
subsequent heating in an oven for 10 min at 120 °C.  
 
9. Iodixanol density gradient for vesicles separation 
Bodipy-Exo in 0.6 mL PBS were loaded on top of a 5-35% (w/v) 
continuous iodixanol (OptiPrep; Sigma-Aldrich) density gradient 
prepared in homogenization medium (HM) (0,25 M sucrose, 1 mM 
EDTA, 10 mM Tris-HCl (pH 7.4)), and centrifuged at 100,000 × g for 16 
hours in a SW60 swinging bucket rotor (Beckman Coulter) at 4 °C. After 
centrifugation, 330 µL fractions were collected and density of each 
fraction was determined by refractometry.  
 
10. Exosome labelling with antibodies for FC 
analysis  
Antibody labelling of Bodipy-Exo was performed according to 
(Kormelink et al., 2016). Briefly, Bodipy-Exo pellet was resuspended in 
15 µL of PE labeled mouse anti-human CD63 (clone H5C6, BD 
Biosciences, catalog# 561925), PE labeled mouse anti-human CD81 
(clone JS-81, BD Biosciences, catalog# 555676), or with PE labeled 
isotype controls, for 60 min at RT. To separate the labeled EVs from 
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antibodies, which will interfere in the FC analysis, a discontinuous 
iodixanol density gradient was prepared. Antibody labeled Bodipy-Exo 
were added to 260 µL of PBS/0.05% BSA, mixed with 1 mL 60% 
iodixanol stock solution and loaded at the bottom of a SW60 tube 
(Beckman Coulter). The iodixanol gradient was obtained by overlaying 
sequentially 0.5 mL 40%, 0.5 mL 30% and 1.8 mL 10% iodixanol 
solutions, prepared by dilution with HM (0,25 M sucrose, 1 mM EDTA, 
10 mM Tris-HCl 7.4). Exosomes floated into the gradient by 
centrifugation in a SW60 rotor (Beckman Coulter) for 18 hours at 
192,000 x g. Gradient fractions of 330 µL were collected from the top of 
the tube and analysed by FC. Fraction densities were determined by 
refractometry. 
 
11. SDS-PAGE and Western blot analysis 
Samples were resuspended in Laemmli sample buffer (Bio-Rad), with or 
without freshly added 50 mM Dithiothreitol (DTT), heated for 10 
minutes at 95 °C and analysed by 10 or 12% sodium dodecyl sulphate–
polyacrylamide gel electrophoresis (SDS–PAGE) and western blot. For 
the analysis of fluorescent proteins patterns gels were directly scanned on 
a Typhoon 9200 gel scanner (Amersham Biosciences). For the analysis 
of Exo markers gels were transferred to Protran Nitrocellulose membrane 
(Amersham Biosciences). Membranes were blocked in 5% skimmed 
milk in TBST (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1% Tween 20) 
for 1 hour at RT. After incubation, membranes were washed three times 
in TBST for 10 minutes at RT and incubated with primary antibodies in 
5% skimmed milk in TBST overnight at 4 °C. The antibodies used were: 
mouse anti-TSG101 1:1000 (GeneTex, catalog# GTX70255), rabbit anti-
HSP90 1:400 (Santa Cruz, catalog# sc-7947), mouse anti-CD81 1:200 
(Santa Cruz, catalog# sc-166029), mouse anti-Flotillin-1 1:1000 (BD 
Biosciences, catalog# 610821), rabbit anti-CD63 1:1000 (System 
Biosciences, catalog# EXOAB-CD63A-1), mouse anti-CD9 1:200 (Santa 
Cruz, catalog# sc-13118), Mouse monoclonal antibody to Alix (3A9 
#MA183977, Thermo Scientific, Waltham, MA USA); Mouse 
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monoclonal antibody to TSG101 (4A10 #GTX70255, GeneTex, Irvine, 
CA USA); Mouse monoclonal antibody to Calnexin (37/Calnexin 
#610524, BD Transduction Laboratories, Lexington, KY USA), Rabbit 
polyclonal antibody to HSP90α/β (H114 #sc7947, Santa Cruz 
Biotechnology, Dallas, TX USA), Rabbit polyclonal antibody to Cofilin 
(#3312, Cell Signaling Thechnology, Leiden, The Netherlands), Goat 
polyclonal antibody to Gelsolin (N-18 #sc6406, Santa Cruz 
Biotechnology, Dallas, TX USA), Mouse monoclonal antibody to 
Tyrosinase (T311 #sc-20035, Santa Cruz, Dallas, TX USA), Rabbit 
polyclonal antibody to Ap2α (C-18 #sc-184-R, Santa Cruz, Dallas, TX 
USA), Mouse monoclonal antibody to E-Cadherin (36/E-
Cadherin#610181, BD Transduction Laboratories™, Lexington, KY 
USA), Rabbit Polyclonal Antibody to N-Cadherin (#NB600-1038, 
Novus, Littleton, CO USA), Mouse monoclonal antibody to α-Tubulin 
(B-5-1-2 #T5168, SIGMA-Aldrich, Saint Louis, MO USA). 
Membranes were then washed three times in TBST for 10 minutes at RT 
and incubated with the appropriate horseradish peroxidase-conjugated 
secondary antibody (Bio-Rad) for 1 hour at RT. Supersignal West Dura 
chemiluminescent substrate (ThermoScientific) was used to detect the 
signals. The band intensities of the western blots were quantified using 
Image J software (NIH). 
 
12. Electron microscopy. 
For immunolabelling, exosome samples were precipitated undiluted at 
room temperature for 15 min to grids. Next, blocking with 0.5% bovine 
serum albumin was performed for 10 min. Labelling with anti-CD63 and 
anti-CD81 antibodies was carried out for 30 min. Following washing 
steps, Prot A Au were added and incubated for 15 min. After subsequent 
phosphate-buffered saline and water wash steps, embedding in 0.3% 
Uranyl acetate in methyl cellulose was finally performed, followed by 
electron microscopy analysis of exosomes. 
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13. Immunoprecipitation.  
Freshly pelleted Bodipy Exo (25x107 vesicles) were labelled with 10 µM 
Succinimidyl ester Alexa Fluor 647 NHS Ester (Life Technologies) in 
PBS for 30 minutes at RT (Bodipy/AF647 Exo) and when required with 
10 µM CFDA-SE (Life Technologies) (Bodipy/AF647/CFSE Exo) for 
30 minutes at RT. Reaction was blocked with 10 mM Glutamine in PBS. 
Bodipy, Bodipy/AF647 and Bodipy/AF647/CFSE Exo were then 
immunoprecipitated by incubating with 10 µg polyclonal anti-Bodipy FL 
(Life Technologies, catalog# A-5770) in PBS in a final volume of 0.5 
mL for 20 hours at 4°C on a roller mixer. 25 µL of Protein A/G beads 
(Pierce) were washed three times with PBS, added to Exo and incubated 
for 1 hour at 4 °C. Pellets were washed twice with PBS for 10 minutes. 
Immunoprecipitation supernatants were analysed by FC to determine 
immunoprecipitation efficiency. Supernatants and pellets were run on a 
10% SDS-PAGE for protein pattern analysis on Typhoon 9200 gel 
scanner (Amersham Biosciences) or analysed for exosome markers by 
western blot.  
 
 
14. Confocal Microscopy 
For Confocal Laser Scanner Microscopy analysis cells were grown on 
sterilized coverslips for 24 h. For pulse–chase studies cells were 
metabolically labelled with 7 µM Bodipy C16, washed in H-BSA, chased 
or not in complete medium before fixation with 3% paraformaldehyde 
(PFA) for 30 min at 4°C, quenched with 10 mM NH4Cl for 10 min at RT 
and analyzed. For cholesterol staining, cells were pulsed for 2 hours with 
7 µM Bodipy C16, fixed in 3% PFA and incubated with 0,05 mg/mL 
Filipin (Sigma-Aldrich, catalog#  F9765) in PBS for 1h in the dark. 
AlexaFluor647-conjugated goat anti mouse (Life Technologies, catalog# 
A21235) was used as secondary antibody. To stain lysosomes, after a 2 
hours pulse with 7 µM Bodipy C16, cells were fixed in 3% PFA and then 
incubated with 1 µM LysoTracker Red DND-99 (Life Technologies, 
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catalog# L7528 ) in PBS for 30 min at 37 °C. For colocalization studies 
cells were pulsed for 2 hours with 7 µM Bodipy C16, permeabilized with 
0,01% Triton X-100 for 10 min at RT and incubated with the following 
antibodies: monoclonal anti-CD63 (ThermoScientific, catalog# MA1-
19281); anti-CD81 (ThermoScientific, catalog# MA5-13548) and 
GM130 (BD Transduction, catalog# 610823); AlexaFluor647-conjugated 
goat anti mouse (Life Technologies, catalog# A21235) was used as 
secondary antibody. 
Coverslips were mounted on the microscope slide with Vectashield 
antifade mounting medium containing DAPI (Vector Laboratories, 
Burlingame, CA). Images were taken by a FV1000 confocal microscope 
(Olympus, Tokyo, Japan), using a (Olympus) planapo objective 60x oil 
A.N. 1,42. Excitation light was obtained by a Laser Dapi 408 nm for 
DAPI, an Argon Ion Laser (488 nm) for C16, a Diode Laser HeNe (561 
nm) for Alexa 555 and a Red Diode Laser (638 nm) for Alexa 647. DAPI 
emission was recorded from 415 to 485 nm, Bodipy C16 emission was 
recorded from 495 to 550 nm, Alexa 555 emission was recorded from 
583 to 628 nm and Alexa 647 from 634 to 750 nm.  
Cells treated with Bodipy Exo were fixed with paraformaldehyde (3%) 
(30 min, 4°C), quenched with 10mM NH4Cl and mounted on the 
microscope slide with Vectashield antifade mounting medium containing 
DAPI (Vector Laboratories, Burlingame, CA). 
Images recorded have an optical thickness of 0.4 mm. Signals from 
different fluorescent probes were taken in sequential scan settings, and 
colocalization was detected in yellow (pseudocolor). Several fields were 
analyzed for each labeling condition, and representative results are 
presented. 
 
15. Mass spectrometry analysis and data 
processing 
Exosomes (8 µg) obtained from ctr or pH6.0-treated MNI cells for 24 h 
incubation in absence of FCS, were separated on precast 4–12% Bis-Tris 
Gels (Invitrogen) and stained with Coomassie Colloidal Blue. Each 
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sample lane was cut into sequential 25 slices. Gel slices were destained 
in 50 mm NH4CO3/CH3CN 1:1 and shrunk in acetonitrile. The 
acetonitrile was removed and the gel particles were dried by 
centrifugation under vacuum. Proteins were reduced (in 10 mm DTT, 25 
mm NH4CO3, for 30 min at 56 °C), shrunk again, and alkylated (55 mm 
iodoacetamide, 25 mm NH4CO3, for 30 min in the dark at room 
temperature). Gel pieces were washed in 50 mm NH4CO3/CH3CN 1:1, 
shrunk in acetonitrile and dried by centrifugation under vacuum. In-gel 
digestion was performed by adding 12.5 ng/µl of trypsin (Promega, 
Madison, WI) in 25 mm NH4CO3 at 37 °C overnight under stirring. 
Supernatants were directly used for mass spectrometry analysis.  
Nano-RPLC was performed using a nano-HPLC 3000 Ultimate (Dionex, 
Sunnyvale, CA ) connected to LTQ-XL linear ion trap (Thermo Fisher). 
Tryptic digests were firstly loaded on a C18 RP-precolumn (300µm 
i.d.x5 mm; 5µm particle size; 100 Å pore size; LC Packings-Dionex,), 
washed by the loading pump at 20µL/min with buffer A (5% ACN, 0.1% 
FA) for 5 min and then on an homemade 12 cm x 75µm- i.d. Silica 
PicoTip (8 ±1µm) column (NewObjective,  Ringoes, NJ ) packed with 
C18AQ (5µm particle size; 200 Å pore size, Michrom Bioresouces Inc.) 
for chromatographic separation. Peptides were eluted at 0.3 µL/min 
along a 40 min linear gradient to 60% of buffer B (95% ACN, 0.1% FA) 
and electrosprayed directly into the mass spectrometer. The acquisition 
was performed in data-dependent Top5 method, with a minimum signal 
threshold of 200 counts and dynamic exclusion enabled for 30 sec. 
Spectra files were analyzed by Sequest HT search engine with Proteome 
Discoverer 1.4 (ThermoFisher) against the Uniprot Human Reviewed 
Protein Database (2014 released version) and decoy database. The 
Carboamidomethylation of cysteines was specified as fixed modification 
and the oxidation of methionine was set as variable modification; mass 
tolerance was set to 1 Da for precursor ion and 0.4 Da for fragment ions 
and a maximum of two missed cleavages was allowed. The Percolator 
tool was used for peptide validation based on the q-value and high 
confidence was chosen, corresponding to a false discovery rate (FDR) 
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≤1% on peptide-level. Proteins were identified with a minimum of 2 
peptides rank=1. 
Three independent experiments were performed. We identified in exo 
(pH6.0) 212, 211 and 217 proteins, and in exo (ctr) 194, 239 and 130 
proteins. Only proteins identified with two peptides in at least two 
experiments were considered, and their abundances were estimated by 
the normalized emPAInorm values according to emPAInorm = emPAI/Σi 
emPAI; where i =1,N and N is the number of proteins [29]. 
Reproducibility assessments were carried out in both cases (pH6.0 and 
control), and the two best correlated experiments (Pearson’s correlation 
higher than 0.8) were considered to calculate the averaged emPAInorm 
value (186 in pH6.0 and 157 in the control) (see Additional file 3).  
The emPAInorm ratio (ρ) between emPAInorm values of proteins 
identified in pH6 and those identified in the control was calculated. 
According with the emPAI ratio proteins were classified as up-regulated 
in pH6.0 (ρ ≥ 1.5), equally regulated in pH6 and in the control (0.5 ≤ ρ ≤ 
1.5) and down-regulated in pH6.0 condition (ρ ≤ 0.5). 
Functional analysis was performed by using the DAVID Bioinformatics 
Resources 6.8 [30]. Proteins up-, equally and down-regulated were 
mapped on KEGG pathways separately and over-represented categories 
(P≤ 10-2) were considered. 
 
16. Bodipy-Exo transfer and functional assays 
To evaluate Bodipy exo transfer to target cells, increasing amounts (40 to 
700 exosome per cell) of exosomes (ctr) and (pH6.0) were added to MNI 
cells in a 96 well plate in duplicate in 100 µl RPMI without serum and 
kept for 2 h at 37 °C in incubator. Then medium was removed, cells 
PBS-washed, detached and subjected to FC analysis as described (Coscia 
et al., 2016). Briefly, fluorescence data of Bodipy Exo, cell samples, and 
QuantumTM FITC-5 MESF (Bangs Laboratories, Inc.) standard curve 
were acquired and transformed into MESF (Molecules of Equivalent 
Soluble Fluorophores) using the QuickCal analysis template provided 
with each QuantumTM MESF lot. Then MESF associated to cells were 
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converted in number of transferred exosomes according the formula: 
(cell fluorescence (MESF)-cell autofluorescence (MESF))/ exosome 
fluorescence (MESF). 
Migration and invasion studies were performed according to standard 
procedures.  
Cell migration was assayed, as previously described (Albini et al., 1987), 
using uncoated cell culture inserts (Corning Costar Corporation, 
Cambridge, MA). Cells were incubated at 37° C in 5% CO2, and after 72 
hr migration was evaluated by a colorimetric assay (Niu et al., 2002) at 
620 nm in a microplate reader (Victor X3, Perkin Elmer). Invasion was 
evaluated as for chemotaxis on culture inserts previously coated with 
matrigel. Cell viability was measured by exclusion of dead cells with 
Trypan Blue Solution (0.4%). 
 
17. Meta-analysis of exosomes molecular cargo 
(PrognoScan). 
PrognoScan is a comprehensive online platform for evaluating potential 
tumor biomarkers and therapeutic targets.  
Based on a large collection of cancer microarray datasets with clinical 
annotation on GEO databases, PrognoScan is a tool to assess the 
association between specific gene expression and prognosis in patients 
with cancer (Mizuno et al., 2009).  
We used this online database to validate metastasis-related proteins 
found upregulated in acidic exosomes with the relative gene expression 
in cancer tissue samples versus Overall Survival (OS) rates of patients 
with metastatic melanoma. 
 
18. Immunohistochemical staining 
Tissue sections from primary cutaneous and metastatic lymph node 
melanoma samples embedded in paraffin were dewaxed and rehydrated. 
For immunolocalization studies slides were first subjected to heat-
mediated antigenic retrieval (10 mM Sodium Citrate buffer pH 6.0) and 
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then to melanin bleaching (warm 10% H2O2). Subsequently slides were 
permeabilizated (0.1% Triton X-100 for 10 min) and saturated (3% BSA 
for at least 2h) at RT. After incubation with primary antibody O/N at 4°C 
(anti Gelsolin ab75832, 1:100, anti Cofilin-1/2 AP08086PU-S Origene 
and ORP150/HSP12A NBP1-32140 Novus 1:50) in humidified chamber, 
slides were incubated with specific fluorophore conjugated secondary 
antibodies (Alexa Fluor, Molecular Probes Eugene, OR, USA) for 45 
min at RT. Ki67 (M7240 Clone MIB-1, Dako) was used as positive 
immunostaining control. Negative controls were performed by omission 
of the primary antibody in each experiment. Finally, slides were mounted 
with SlowFade anti-fade reagent containing DAPI (Molecular Probes, 
Eugene, OR, USA) and analyzed by Olympus F1000 laser-scanning 
confocal microscopy (Olympus,Tokyo, Japan). 
 
19. Statistical analysis 
Differences were statistically evaluated using two-tailed Student’s t test. 
Values were considered significant at P < 0.05. All data are expressed as 
the mean ± SEM from at least three separate experiments. In some 
experiments one-way ANOVA multiple comparison analysis with 
Tukey’s post test was used. For OS analysis, Mentel-Cox p-values < 00.5 
were considered as statistically significant. 	
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ABBREVIATIONS 
ALIX, ALG-2 interacting protein X; Bodipy C16, BODIPY FL C16; 
Bodipy-Exo, exosome labelled with BodipyFL C16; BMP, 
bis(monoacylglyceryl)phosphate; BSA, bovine serum albumin; CHOL, 
cholesterol; CFL, Cofilin; EMT, epithelial-mesenchymal transition; EP, 
early primary melanoma; ER, endoplasmic reticulum; ESCRT, 
endosomal sorting complex required for transport; EV, extracellular 
vesicle; Exo, exosomes; FC, Flow Citometry; GANAB, glucosidase II 
alpha subunit; GSN, Gelsolin; H-BSA, hank’s balanced salt solution 
supplemented with BSA; HPTLC, High Performance Thin Layer 
Chromatography; HRAS, HRas proto-oncogene; HSP90AB1, heat shock 
protein 90 alpha family class B member; HSPA5, heat shock protein 
family A member 5; HSPAIL,  heat shock protein family A member I 
like; HYOU1, hypoxia up-regulated; IHC, immunohistochemistry; ILV, 
intraluminar vesicles; MI metastatic invasive melanoma; MNI, 
metastatic non invasive melanoma; MVE, multi vesicular endosome; 
MV, microvesicles; NHS-AF647, AlexaFluor647-conjugated 
Succinimidyl Ester; NRAS, neuroblastoma RAS oncogene; PE,  
phosphatidylethanolamine; PI, primary invasive melanoma; PI, 
phosphatidylinositol; PS,  phosphatidylserine; TAG, triacylglycerol; 
TIMP3, Timp metallopeptidase inhibitor 3; TSG101, tumor 
susceptibility gene 101. 
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